FDA Authorizes Innovative Non-Invasive Device for Locally Advanced Pancreatic Cancer
February 16, 2026
Brand Name :
Enablex
Synonyms :
darifenacin
Class :
Anticholinergics, Genitourinary
Dosage forms & Strengths:
Adult:
Extended-release tablet
7.5 mg
15 mg
Safety and efficacy are not seen in pediatrics
Refer to the adult dosing
may decrease the metabolism when combined
It may enhance the effect when combined with miconazole vaginal by affecting CYP3A4 metabolism
darifenacin can impact the hepatic/intestinal enzyme CYP3A4 metabolism, leading to an elevation in the level or potency of intranasal midazolam
it may diminish the therapeutic efficacy when combined with castor oil
darifenacin: they may enhance the serum concentration of CYP3A4 Inhibitors
darifenacin: they may enhance the serum concentration of CYP3A4 Inhibitors
darifenacin: they may enhance the serum concentration of CYP3A4 Inhibitors
darifenacin: they may enhance the serum concentration of CYP3A4 Inhibitors
darifenacin: they may enhance the serum concentration of CYP3A4 Inhibitors
darifenacin: they may enhance the serum concentration of CYP3A Inhibitors
darifenacin: they may enhance the serum concentration of CYP3A Inhibitors
darifenacin: they may enhance the serum concentration of CYP3A Inhibitors
darifenacin: they may enhance the serum concentration of CYP3A Inhibitors
darifenacin: they may enhance the serum concentration of CYP3A Inhibitors
When encainide is used together with darifenacin, this leads to a reduction in the encainide’s metabolism
When indisulam is used together with darifenacin, this leads to a reduction in darifenacin metabolism
When darifenacin is used together with profenamine, this leads to enhanced risk or seriousness of adverse events
the therapeutic activity of calcium polycarbophyl may be decreased
the therapeutic activity of darifenacin may be reduced
the therapeutic activity of darifenacin may be reduced
When darifenacin is used together with oliceridine, this leads to enhanced concentration serum of oliceridine
Actions and Spectrum:
darifenacin is a medication that belongs to a class of drugs called antimuscarinics. It works by blocking the action of a chemical messenger in the body called acetylcholine, which helps to relax the bladder and urinary tract muscles. It can help reduce overactive bladder symptoms, such as frequent urination and urgent need to urinate. Darifenacin is typically used to treat urinary incontinence and urinary urgency.
>10%:
Constipation (15-21%)
Dry mouth (19-35%)
1-10%:
Dry eyes (2%)
Dyspepsia (3-8%)
Abdominal pain (2-4%)
Dizziness (2%)
Vaginitis (>1%)
Back pain (>1
Vomiting (>1%)
Weight gain (>1%)
Abnormal vision (>2%)
Peripheral edema (>1%)
Flu-like syndrome (1-3%)
Black Box Warning:
It is essential to follow the dosage and administration instructions for the medication carefully.
Contraindication/Caution:
darifenacin should not be used in people hypersensitive to the drug itself.
Pregnancy consideration:
No data is available regarding the usage of the drug during pregnancy.
Breastfeeding warnings:
No data is available regarding the secretion of the drug in breast milk.
Pregnancy category:
Pharmacology
darifenacin is a medication that belongs to a class of drugs called antimuscarinics. It works by blocking the action of the chemical messenger acetylcholine in the body. Specifically, darifenacin selectively blocks M3 muscarinic receptors in the bladder and urinary tract smooth muscle. It helps to relax the bladder and urinary tract muscles, which can reduce symptoms of an overactive bladder, such as frequent urination and urgent need to urinate.
Pharmacodynamics:
darifenacin is an antimuscarinic medication. It works by blocking the action of the chemical messenger acetylcholine in the body. Specifically, darifenacin selectively blocks M3 muscarinic receptors in the bladder and urinary tract smooth muscle.
When acetylcholine binds to these receptors, it causes the muscles in the bladder and urinary tract to contract. By blocking this binding, darifenacin helps to relax these muscles. It reduces overactive bladder symptoms such as urinary urgency, frequency, and incontinence.
Pharmacokinetics:
Pharmacokinetics studies how a drug is absorbed, distributed, metabolized, and eliminated by the body. The pharmacokinetics of darifenacin can be summarized as follows:
Absorption
darifenacin is well absorbed after oral administration, with a bioavailability of about 70%. It can be taken with or without food but taking it with food may decrease the absorption rate.
Distribution
darifenacin is highly protein-bound and has a large volume of distribution. It can cross the blood-brain barrier, which allows it to reach the CNS and cause side effects such as dry mouth, constipation, blurred vision, and drowsiness.
Metabolism
darifenacin is metabolized in the liver by CYP3A4 enzymes. Its primary metabolite is 5-hydroxymethyl darifenacin which is pharmacologically active.
Elimination and excretion
darifenacin is eliminated mainly by the kidneys. The elimination half-life of darifenacin is about 20 hours, which means it takes about 20 hours for half of the drug to be eliminated from the body.
Administration:
Do not crush or chew the tablet.
Take one tablet at a time, with fluids or water.
Patient information leaflet
Generic Name: darifenacin
Pronounced: da-ri-fen-acin
Why do we use darifenacin?
darifenacin is used to treat overactive bladder.